For any questions related to filing articles (including electronic filing, if available), please visit the journal`s website. You can track accepted articles on www.elsevier.com/trackarticle and set up email notifications to let you know when an article`s status has changed. From there, information on copyright, frequently asked questions and much more is also available. Contact information on issues that arise after the adoption of an article, including the evidence, is provided by the publisher. All manuscripts submitted to the Journal of Nuclear Medicine are accompanied by a letter from the author responsible for the correspondence of the manuscript. The cover letter must contain the following declaration of copyright disclosure pursuant to the Copyright Revision Act of 1976, valid on January 1, 1978. This declaration must be signed by all co-authors. Name “First Author” and “Corresponding Author” in parentheses by their signatures. This copyright transfer requirement does not apply to work prepared by U.S. government personnel as part of their official duties. The author (s) also assures the JPTM that the article is the author`s original work, with the exception of material in the public domain and works other than those that may be contained with the written permission of copyright holders; The article has not previously been published, presented or accepted elsewhere (in any language) for publication; that the authors have made a significant contribution to this document, understand it and support it. Conditions 1 to 3 (see paragraph 1 of the copyright transfer letter) must be met by all co-authors and this declaration must be signed by all co-authors.
If figures or tables have been published in advance in the manuscript, it should be recognized and written permission to be included in the presentation of the manuscript. Figure 1 shows XRD samples from the ZnS, Cu (0.1) ZnS, Ga (0.1) and GN (0.1), Cu (x) ZnS powder samples. Distinctive peaks are 2 x 28.6, 32.5, 47.6 and 56.3, respectively, which corresponds to the level (111), (200), (220) and (311), which is a typical model of the cubic zinc mixing phase [22, 23]. For ZnS, there are bits of shoulders. This is due to the hexagonal phase of ZnS (100) and (002) which is consistent with the values reported with a similar synthesis temperature . With respect to the cu sample (0.1) ZnS, there is a large tip of the shoulder where the level (101) of CuS  could be located. This peak has a different shape from the tip of the ZnS shoulder in the same place. In addition, the summit disappeared at Cu (0.1) ZnS. It is also observed that there is a shoulder tip on and corresponding (006) and (116) CuS level, respectively [26, 27].
This confirms that the Cu (0.1) ZnS phases were present in the sample. The author hereafter forwards all copyrights in and on the above manuscript in all the forms and media mentioned above, which are now or later known, to the Korean Society of Pathology and the Korean Society for Cytopathology, when the document is adopted for publication in the Journal of Pathology and Translational Medicine. Authors reserve all property rights other than copyrights, such as patent rights. Sending Statement and Verification The filing of an article implies that the book described has not been published before (except in the form of a summary, conference or scientific thesis, See “Multiple, redundant or simultaneous publication” for more information), that it is not envisaged to be published elsewhere, that its publication is authorized by all authors and implicitly or explicitly by the competent authorities in which the book was produced and that, if accepted, it will not be published elsewhere in the same form, in English or in another language, including electronically without the written consent of the author.